Stem cell injection for severe ARDS
Part of Lungs & breathing clinical trials.
This trial tests whether an injection of stem cells from umbilical cords can help people with severe ARDS (a type of lung failure) recover faster. It is for those who have not improved after standard treatment and whose ARDS is caused by an infection (not COVID-19).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 80 years old and have been diagnosed with moderate or severe ARDS caused by an infection.
- Your condition has not improved after at least 24 hours of standard treatment.
- You can provide written consent and follow all study procedures for long-term follow-up.
- You do not have ARDS from COVID-19, active infections like hepatitis or TB, serious heart or lung conditions, or severe bleeding problems.
- You are not on ECMO, have not had a blood clot in the past 6 months, and are not pregnant or planning pregnancy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment using stem cells from umbilical cords, given through an IV, for people with severe ARDS. The goal is to see if it's safe and helps improve breathing.
This trial tests a treatment made from human umbilical cord stem cells for people with moderate ARDS. The goal is to see if it is safe and well-tolerated, and if it might help the lungs recover faster.
This trial tests a new stem cell treatment made from umbilical cord cells for people with ARDS, a serious lung condition. The treatment may help reduce inflammation and improve lung function.
This trial tests if adding stem cells or their growth liquid to standard sepsis treatment helps adults with severe breathing problems. It may improve recovery for those whose family agrees to the study.
This trial is testing new treatments for people with ARDS, a serious lung condition. The goal is to find therapies that help patients breathe better and recover faster. If you or a loved one has ARDS, this study may offer access to experimental treatments.
This Phase 3 trial studies an “extracellular vesicle” treatment in people with moderate to severe ARDS, a serious lung breathing problem. The goal is to see whether the treatment can improve outcomes compared with standard care.
Hear when a new Acute Respiratory Distress Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.